Detection of microRNA expressions in tissues and exfoliative cells reveals the potential role of miR-203 in oral lichen planus
Zhendong Feng;Wen Shi;Zhigang Cai;Hong Hua;Demin Zhou;State Key Laboratory of Natural and Biomimetic Drugs;Department of Chemical Biology;School of Pharmaceutical Sciences;Peking University Health Science Center;School and Hospital of Stomatology;Peking University;

..............page:279-286

Development of targeted sunitinib plus vinorelbine liposomes modified with DSPE-PEG₂₀₀₀-pemetrexed conjugate and the inhibitory effect toresistant breast cancer in vitro
Jifeng Shi;Ruijun Ju;Mengge Sun;Xiuying Li;Yao Zhao;Fan Zeng;Wanliang Lu;State Key Laboratory of Natural and Biomimetic Drugs;Department of Pharmaceutics;School of Pharmaceutical Sciences;Peking University Health Science Center;

..............page:287-294

Intervention of multiple pathways by multiple active components provides potent protection against cerebral ischemia injury
Jingliang Zhanga;Tao Hua;Xiaoyan Liu;Yuanjun Zhu;Yinye Wang;Department of Molecular and Cellular Pharmacology;School of Pharmaceutical Sciences;Peking University Health Science Center;

..............page:295-301

Characterization of two degradation products of Azilsartan formed during the micronization process and development of a method to control the degradation
Lipeng Sui;Ridong Li;Bo Song;Moyi Liu;R&D Center;China Resources Saike Pharmaceutical Co.;Ltd.;

..............page:302-305

A new indole alkaloid from Nauclea officinalis(Pierre ex Pitard) Merr. et Chun
Xiaoxue Pi;Kehui Xie;Guangzhong Tu;Tianzhi Cai;Rong Yang;Qiong Wu;Hongzheng Fu;State Key Laboratory of Natural Biomimetic Drugs;School of Pharmaceutical Science;Peking University Health Science Center;Beijing Institute of Microchemistry;

..............page:306-310

Biotransformation of methyleugenol by rat hepatic microsomes
Guiyun Cao;Xiuwei Yang;State Key Laboratory of Natural and Biomimetic Drugs;Department of Natural Medicines;School of Pharmaceutical Sciences;Peking University Health Science Center;

..............page:311-316

Comparative study on different derivatization procedures for analysis of recombinant human erythropoietin by capillary electrophoresis with laser-induced fluorescence detection
Xia Yang;Nannan Pang;Xiaofang Fu;Hongfeng Yin;Yiping Liao;Huwei Liu;The Key Lab of Bioorganic Chemistry and Molecular Engineering of Ministry of Education;Institute of Analytical Chemistry;College of Chemistry and Molecular Engineering;Peking University;School of Chemical and Biological Engineering;University of Science and Technology Beijing;Agilent Labs;Santa Clara;CA 95051 USA;

..............page:317-323

The impact of drug administration in USA, Europe and Japan on the reform plan in China
Xiaoyuan Zheng;Shixia Zhang;Song Yang;Yanyan Li;Bin Jiang;Department of Administrative and Clinical Pharmacy;School of Pharmaceutical Sciences;Peking University Health Science Center;China Food and Drug Administration;

..............page:324-329

Participation of clinical pharmacist specialized in oncology in the treatment of a patient with advanced esophageal carcinoma complicated with hypertension: one case report
Zeng Wang;Haiying Ding;Meiqin Yuan;Nengming Lin;Department of Pharmacy;Zhejiang Cancer Hospital;Department of Chemotherapy;Zhejiang Cancer Hospital;Institute for Individualized Medicine;Hangzhou First People’s Hospital;

..............page:330-334

Application of recombinant enzymes in the production of human insulin
Chunsheng Leng;Hang Cui;Shunan Li;Tonghua Dongbao Pharmaceutical Co. Ltd.;

..............page:335-337

jiang ya wu jian jie 
bian ji bu ;

..............page:338-339

Drug development guidelines for Hepatitis C virus——From a Clinical Perspective
Debra Birnkrant;Division of Antiviral Products in the Office of Antimicrobial Products;CDER’s Office of New Drugs;

..............page:340-341

FDA approves Zontivity to reduce the risk of heart attacks and stroke in high-risk patients

..............page:342

Information for Authors
bian ji bu ;

..............page:343